Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001387131-18-001080
Filing Date
2018-03-16
Accepted
2018-03-15 17:34:21
Documents
97
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT admp_10k-123117.htm 10-K 1163205
2 MARCH 2018 AMENDMENT TO LOAN AND SECURITY AGREEMENT ex10-78.htm EX-10.78 16479
3 MARCH 2018 AMENDED AND RESTATED LINE OF CREDIT PROMISSORY NOTE ex10-79.htm EX-10.79 32902
4 SUBSIDIARIES OF THE REGISTRANT ex21-1.htm EX-21.1 4135
5 AUDITOR'S CONSENT ex23-1.htm EX-23.1 3161
6 CERTIFICATION BY CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 11351
7 CERTIFICATION BY CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 11553
8 CERTIFICATION BY CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 5299
9 CERTIFICATION BY CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 5755
  Complete submission text file 0001387131-18-001080.txt   6392507

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT admp-20171231.xml EX-101.INS 1075043
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT admp-20171231.xsd EX-101.SCH 62804
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT admp-20171231_cal.xml EX-101.CAL 107454
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT admp-20171231_def.xml EX-101.DEF 293652
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT admp-20171231_lab.xml EX-101.LAB 517470
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT admp-20171231_pre.xml EX-101.PRE 425045
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36242 | Film No.: 18693500
SIC: 2834 Pharmaceutical Preparations